A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers
2012 ◽
Vol 1
(1)
◽
pp. 24-31
◽
Keyword(s):
Phase 1
◽